Isabel Conde Del Moral

Ms. Isabel Conde Del Moral

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2007 in Cellular Signalling
Verified
Journal Article
Closed access
GOGemma Olmos
Gemma Olmos
IMIsabel Conde Del Moral
Isabel Conde Del Moral
IAIsabel Arenas
Isabel Arenas
Luis Del PesoLuis Del Peso
Luis Del Peso
CCCarmen Castellanos
Carmen Castellanos
FLFrancisco Javier Lucio-Cazaña
Francisco Javier Lucio-Cazaña

11 January 2020 in Plants
Verified
Journal Article
Open access
PDF file
BMBelmari Mendez
Belmari Mendez
JRJeyshka Reyes-González
Jeyshka Reyes-González
IMIsabel Conde Del Moral
Isabel Conde Del Moral
ZRZulma Ramos
Zulma Ramos
ELEunice Lozada-Delgado
Eunice Lozada-Delgado
Claudia Andrea Ospina-MillánClaudia Andrea Ospina-Millán
Claudia Andrea Ospina-Millán
Species of the genus Simarouba have been studied because of their antimalarial and antileukemic activities. A group of oxygenated terpenes called quassinoids have been isolated from species of the Simarouba genus, and are responsible for its therapeutic properties. We hypothesized that Simarouba tulae, an endemic plant from Puerto Rico, is a natural source rich in quassinoid compounds with anticancer activity. The leaves were processed and extracted with solvents of different polarities. The extracts were screened for their antiproliferative activity, and it was shown that the chloroform extract was the most active extract. This extract was purified using different chromatographic techniques to afford the quassinoid simalikalactone D (SKD). This compound was further characterized using NMR and X-ray diffraction analysis. A reassessment of original structural assignments for SKD is proposed. SKD showed high cytotoxicity activity, with an IC50 of 55, 58, and 65 nM in A2780CP20 (ovarian), MDA-MB-435 (breast), and MDA-MB-231 (breast) cell lines, respectively. Exposure to SKD led to 15% inhibition of the migration of MDA-MB-231 cells.